Credit rating agency-- India Ratings and Research (Ind-Ra) has assigned rating to Shilpa Medicare’s long term rating at ‘A+/Stable’ and short term rating at ‘A+/Stable/A1’ against the existing ratings of long term rating of ‘A (Stable)’ and short term rating of ‘A1’ assigned by ICRA.
Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.